Effect of sequential preparation with ethinyl estradiol sulfonate soft gelatin capsules and norethindrone acetate on carbohydrate metabolism
Nikschick, S.; Göretzlehner, G.; Männchen, E.; Brachmann, K.
Zentralblatt für Gynakologie 106(6): 368-373
1984
ISSN/ISBN: 0044-4197 PMID: 6372333 Document Number: 224850
An intravenous glucose tolerance test (i.v.GTT) was done before and after 6 months of using a sequential-type oral contraceptive in form of a weekly pill containing 0,6 mg ethinylestradiol-sulfonate (EES) soft gelatin capsules and 10 mg norethisterone acetate (NEA). 17 fertile, eumetabolic women are examined . There was no change neither average fasting blood glucose nor glucose assimilation after intake of ethinylestradiol. Basal as well as reactive insulin values increased by longer period of intake.
Document emailed within 1 workday
Related Documents
Hanson, F.W.; Niswander, K.R. 1974: A new low dose norethindrone acetate (0.6 mg) ethinyl estradiol (30 mcg) combination oral contraceptive Journal of Reproductive Medicine 12(3): 109-111DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Grandi, G.; Napolitano, A.; Xholli, A.; Tirelli, A.; Di Carlo, C.; Cagnacci, A. 2015: Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 31(10): 774-778
Neely, J.L.; Abate, M.; Swinker, M.; D'Angio, R. 1991: The effect of doxycycline on serum levels of ethinyl estradiol, norethindrone, and endogenous progesterone Obstetrics and Gynecology 77(3): 416-420
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Xiao, W.; Ma, Y.; Deng, H.-z.; Wei, L.-b. 2005: Effect of the Yifuning soft gelatin capsules on estrogen receptor and nitric oxide levels in ovariectomized rats Zhongguo Zhong Yao Za Zhi 30(20): 1598-1602
Lippert, C.; Seeger, H.; Wallwiener, D.; Mueck, A.O. 2001: The effect of medroxyprogesterone acetate and norethisterone on the estradiol stimulated proliferation in MCF-7 cells: comparison of continuous combined versus sequential combined estradiol/progestin treatment European Journal of Gynaecological Oncology 22(5): 331-335
Klipping, C.; Marr, J. 2005: Effects of two combined oral contraceptives containing ethinyl estradiol 20 μg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception (Stoneham) 71(6): 409-416
Pasquale, S.A.; Yuliano, E. 1975: Clinical results with a new low dose oral contraceptive utilizing norethindrone/ethinyl estradiol Contraception 12(5): 495-503
Ruíz Moreno, J.A.; Rubio Lotvin, B.; Bolio Arista, R.; de Larios, N.M. 1977: A continuous experience of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive Ginecologia y Obstetricia de Mexico 41(244): 179-184
Pyörälä, T.; Vähäpassi, J.; Huhtala, M. 1979: The effect of lynestrenol and norethindrone on the carbohydrate and lipid metabolism in subjects with gestational diabetes Annales Chirurgiae et Gynaecologiae 68(2): 69-74
Mildvan, D.; Yarrish, R.; Marshak, A.; Hutman, H.W.; McDonough, M.; Lamson, M.; Robinson, P. 2002: Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women Journal of Acquired Immune Deficiency Syndromes 29(5): 471-477
Garg, V.; van Heeswijk, R.; Yang, Y.; Kauffman, R.; Smith, F.; Adda, N. 2012: The pharmacokinetic interaction between an oral contraceptive containing ethinyl estradiol and norethindrone and the HCV protease inhibitor telaprevir Journal of Clinical Pharmacology 52(10): 1574-1583
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
Gaussem, P.; Alhenc-Gelas, M.; Thomas, J.-L.; Bachelot-Loza, C.; Remones, V.; Ali, F.D.; Aiach, M.; Scarabin, P.-Y. 2011: Haemostatic effects of a new combined oral contraceptive, nomegestrol acetate/17β-estradiol, compared with those of levonorgestrel/ethinyl estradiol. a double-blind, randomised study Thrombosis and Haemostasis 105(3): 560-567
Kovarik, J.M.; Mueller, E.A.; Johnston, A.; Hitzenberger, G.; Kutz, K. 1993: Bioequivalence of soft gelatin capsules and oral solution of a new cyclosporine formulation PharmacoTherapy 13(6): 613-617
Lin, W.H.; Feng, H.-P.; Shadle, C.R.; O'Reilly, T.; Wagner, J.A.; Butterton, J.R. 2014: Pharmacokinetic and pharmacodynamic interactions between the hepatitis C virus protease inhibitor, boceprevir, and the oral contraceptive ethinyl estradiol/norethindrone European Journal of Clinical Pharmacology 70(9): 1107-1113
Grandi, G.; Piacenti, I.; Volpe, A.; Cagnacci, A. 2014: Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 30(9): 676-680
Facchini, G.; Filippi, G.; Valier, R.; Nannetti, M. 1985: Assay of parabens released from soft gelatin capsules to triglycerides of fatty acids by means of HPLC Bollettino Chimico Farmaceutico 124(7): 340-344
Laumas, V.; Malik, B.K.; Jamal, K.; Seth, U.; Agarwal, N.; Hingorani, V.; Laumas, K.R. 1978: Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate Contraception 18(6): 593-605